Back to Search Start Over

Tr-KIT/c-KIT ratio in renal cell carcinoma

Authors :
Diler Us Altay
Sercan Ergun
Sezgin Gunes
Süleyman Caner Karahan
Leman Tomak
Recep Büyükalpelli
Ummet Abur
Ondokuz Mayıs Üniversitesi
Source :
Molecular biology reports. 46(5)
Publication Year :
2019

Abstract

Gunes, Sezgin/0000-0002-3103-6482; us altay, diler/0000-0002-0465-8403; abur, ummet/0000-0002-4811-9321 WOS: 000495590600059 PubMed: 31342295 Truncated KIT (tr-KIT) is an alternative variant of c-KIT protein. Previous studies have clearly documented that c-KIT was associated with various oncogenic processes in RCC. However, the biological significance of tr-KIT in RCC development and progression remains unclear. So, it was aimed to investigate the possible association between RCC and tr-KIT which is thought to activate some oncogenic pathways. In this study, Kidney Cancer cDNA Array containing a total of 48 cDNA samples from the normal kidney tissues of 9 healthy subjects and kidney tumor tissues of 10 stage-1, 5 stage-2, 13 stage-3 and 11 stage-4 RCC patients was used for gene expression analysis. Real-Time PCR method was used to measure tr-KIT/c-KIT expression ratios. tr-KIT/c-KIT expression ratio was compared between tumor and normal samples, and statistically correlated with the clinical parameters of RCC patients. tr-KIT/c-KIT expression ratio was approximately 4-times higher in tumor samples than control ones (p = 0.001). Also, tr-KIT/c-KIT expression ratio was approximately two, three and six times higher in Fuhrman nuclear grades 2, 3 and 4 than normal, respectively (p = 0.009). Moreover, clear cell and papillary RCC has a significantly higher level of tr-KIT/c-KIT expression ratio than chromophobe RCC (p = 0.016). In the current study, it was stated for the first time that tr-KIT/c-KIT expression ratio was up-regulated in RCC tissues, and high tr-KIT/c-KIT expression ratio was correlated with more aggressive clinical features and poor patient prognosis. Our results suggest that increased tr-KIT/c-KIT expression ratio might be useful as a prognostic marker for RCC patients. Scientific & Technological Research Council of Turkey (TUBITAK)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [118S162] This study was funded by The Scientific & Technological Research Council of Turkey (TUBITAK) (Grant No: 118S162).

Details

ISSN :
15734978
Volume :
46
Issue :
5
Database :
OpenAIRE
Journal :
Molecular biology reports
Accession number :
edsair.doi.dedup.....24083e194229b9e814366ec23d84de36